**6. References**


[CIBERNED and RETICS (RD06/0010/0006; Red de Terapia Celular)] and Generalitat de Catalunya (2009SGR-00326), Spain. The Cell Therapy Program is supported by the Centre of Regenerative Medicine in Barcelona (CMRB; Promt-0901), Generalitat de Catalunya, Spain.

Adler, S., Pellizzer, C., Paparella, M., Hartung, T., & Bremer, S. (2006). The effects of solvents

Amano, M., Chihara, K., Kimura, K., Fukata, Y., Nakamura, N., Matsuura, Y., & Kaibuchi, K.

Amit, M., Carpenter, M.K., Inokuma, M.S., Chiu, C.P., Harris, C.P., Waknitz, M.A., Itskovitz-

Amit, M., Shariki, C., Margulets, V., & Itskovitz-Eldor, J. (2004). Feeder layer- and serum-

Apostolou, E. & Hochedlinger, K. (2011). Stem cells: iPS cells under attack. *Nature*, Vol. 474,

Battey, J.F. (2007). Stem cells: current challenges and future promise. *Dev. Dyn.*, Vol. 236, No.

Baust, J.G., Gao, D., & Baust, J.M. (2009). Cryopreservation: An emerging paradigm change.

Baust, J.M., Vogel, M.J., Van, B.R., & Baust, J.G. (2001). A molecular basis of

Berz, D., McCormack, E.M., Winer, E.S., Colvin, G.A., & Quesenberry, P.J. (2007).

Birraux, J., Genin, B., Matthey-Doret, D., Mage, R., Morel, P., & Le, C.C. (2002). Hepatocyte

Bosma, G.C., Custer, R.P., & Bosma, M.J. (1983). A severe combined immunodeficiency

Carpenter, M.K., Rosler, E., & Rao, M.S. (2003). Characterization and differentiation of human embryonic stem cells. *Cloning Stem Cells*, Vol. 5, No. 1, pp. (79-88) Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., & Smith, A. (2003).

Chin, M.H., Mason, M.J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G.,

mutation in the mouse. *Nature*, Vol. 301, No. 5900, pp. (527-530)

embryonic stem cells. *Cell*, Vol. 113, No. 5, pp. (643-655)

cryopreservation failure and its modulation to improve cell survival. *Cell* 

Cryopreservation of hematopoietic stem cells. *Am. J. Hematol.*, Vol. 82, No. 6, pp.

cryopreservation in a three-dimensional structure. *Transplant. Proc.*, Vol. 34, No. 3,

Functional expression cloning of Nanog, a pluripotency sustaining factor in

Aimiuwu, O., Richter, L., Zhang, J., Khvorostov, I., Ott, V., Grunstein, M., Lavon, N., Benvenisty, N., Croce, C.M., Clark, A.T., Baxter, T., Pyle, A.D., Teitell, M.A., Pelegrini, M., Plath, K., & Lowry, W.E. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. *Cell Stem* 

kinase. *Science*, Vol. 275, No. 5304, pp. (1308-1311)

culture. *Dev. Biol.*, Vol. 227, No. 2, pp. (271-278)

*Organogenesis.*, Vol. 5, No. 3, pp. (90-96)

*Transplant.*, Vol. 10, No. 7, pp. (561-571)

*Cell*, Vol. 5, No. 1, pp. (111-123)

on embryonic stem cell differentiation. *Toxicol. In Vitro*, Vol. 20, No. 3, pp. (265-271)

(1997). Formation of actin stress fibers and focal adhesions enhanced by Rho-

Eldor, J., & Thomson, J.A. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of

free culture of human embryonic stem cells. *Biol. Reprod.*, Vol. 70, No. 3, pp. (837-

**6. References** 

845)

No. 7350, pp. (165-166)

12, pp. (3193-3198)

(463-472)

pp. (764-767)


Cryopreservation of Human Pluripotent Stem Cells: Are We Going in the Right Direction? 161

Klimanskaya, I., Chung, Y., Becker, S., Lu, S.J., & Lanza, R. (2006). Human embryonic stem cell lines derived from single blastomeres. *Nature*, Vol. 444, No. 7118, pp. (481-485) Koebe, H.G., Dunn, J.C., Toner, M., Sterling, L.M., Hubel, A., Cravalho, E.G., Yarmush, M.L.,

a sandwich culture configuration. *Cryobiology*, Vol. 27, No. 5, pp. (576-584) Koebe, H.G., Muhling, B., Deglmann, C.J., & Schildberg, F.W. (1999). Cryopreserved porcine hepatocyte cultures. *Chem. Biol. Interact.*, Vol. 121, No. 1, pp. (99-115) Krawetz, R.J., Li, X., & Rancourt, D.E. (2009). Human embryonic stem cells: caught between a ROCK inhibitor and a hard place. *Bioessays*, Vol. 31, No. 3, pp. (336-343) Lee, J.Y., Lee, J.E., Kim, D.K., Yoon, T.K., Chung, H.M., & Lee, D.R. (2010). High

Li, T., Mai, Q., Gao, J., & Zhou, C. (2010a). Cryopreservation of human embryonic stem cells with a new bulk vitrification method. *Biol. Reprod.*, Vol. 82, No. 5, pp. (848-853) Li, T., Zhou, C., Liu, C., Mai, Q., & Zhuang, G. (2008a). Bulk vitrification of human

Li, X., Krawetz, R., Liu, S., Meng, G., & Rancourt, D.E. (2009). ROCK inhibitor improves

Li, X., Meng, G., Krawetz, R., Liu, S., & Rancourt, D.E. (2008b). The ROCK inhibitor Y-27632

Li, Y., Tan, J.C., & Li, L.S. (2010b). Comparison of three methods for cryopreservation of human embryonic stem cells. *Fertil. Steril.*, Vol. 93, No. 3, pp. (999-1005) Lin, G., Ouyang, Q., Zhou, X., Gu, Y., Yuan, D., Li, W., Liu, G., Liu, T., & Lu, G. (2007). A

Maekawa, M., Ishizaki, T., Boku, S., Watanabe, N., Fujita, A., Iwamatsu, A., Obinata, T.,

Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M.,

Mahler, S., Desille, M., Fremond, B., Chesne, C., Guillouzo, A., Campion, J.P., & Clement, B.

Mai, Q., Yu, Y., Li, T., Wang, L., Chen, M.J., Huang, S.Z., Zhou, C., & Zhou, Q. (2007).

tissue contribution. *Cell Stem Cell*, Vol. 1, No. 1, pp. (55-70)

*Cell Res.*, Vol. 17, No. 12, pp. (1008-1019)

embryonic stem cells. *Hum. Reprod.*, Vol. 23, No. 2, pp. (358-364)

cryopreservation. *Stem Cells Dev.*, Vol. 17, No. 6, pp. (1079-1085)

*Fertil. Steril.*, Vol. 93, No. 3, pp. (976-985)

*Hum. Reprod.*, Vol. 24, No. 3, pp. (580-589)

Vol. 17, No. 12, pp. (999-1007)

5429, pp. (895-898)

592)

& Tompkins, R.G. (1990). A new approach to the cryopreservation of hepatocytes in

concentration of synthetic serum, stepwise equilibration and slow cooling as an efficient technique for large-scale cryopreservation of human embryonic stem cells.

survival of cryopreserved serum/feeder-free single human embryonic stem cells.

enhances the survival rate of human embryonic stem cells following

highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. *Cell Res.*,

Ohashi, K., Mizuno, K., & Narumiya, S. (1999). Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. *Science*, Vol. 285, No.

Yachechko, R., Tchieu, J., Jaenisch, R., Plath, K., & Hochedlinger, K. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread

(2003). Hypothermic storage and cryopreservation of hepatocytes: the protective effect of alginate gel against cell damages. *Cell Transplant.*, Vol. 12, No. 6, pp. (579-

Derivation of human embryonic stem cell lines from parthenogenetic blastocysts.


Heng, B.C., Clement, M.V., & Cao, T. (2007). Caspase inhibitor Z-VAD-FMK enhances the

Heng, B.C., Ye, C.P., Liu, H., Toh, W.S., Rufaihah, A.J., Yang, Z., Bay, B.H., Ge, Z., Ouyang,

Holm, F., Strom, S., Inzunza, J., Baker, D., Stromberg, A.M., Rozell, B., Feki, A., Bergstrom,

Hovatta, O., Mikkola, M., Gertow, K., Stromberg, A.M., Inzunza, J., Hreinsson, J., Rozell, B.,

Hu, E. & Lee, D. (2005). Rho kinase as potential therapeutic target for cardiovascular

Hubel, A. (1997). Parameters of cell freezing: implications for the cryopreservation of stem

Hunt, C.J. (2011). Cryopreservation of Human Stem Cells for Clinical Application: A

Hunt, C.J. & Timmons, P.M. (2007). Cryopreservation of human embryonic stem cell lines.

Ishizaki, T., Naito, M., Fujisawa, K., Maekawa, M., Watanabe, N., Saito, Y., & Narumiya, S.

Ji, L., de Pablo, J.J., & Palecek, S.P. (2004). Cryopreservation of adherent human embryonic

Karlsson, J.O. (2002). Cryopreservation: freezing and vitrification. *Science*, Vol. 296, No. 5568,

Karlsson, J.O. & Toner, M. (1996). Long-term storage of tissues by cryopreservation: critical

Katkov, I.I., Kan, N.G., Cimadamore, F., Nelson, B., Snyder, E.Y., & Terskikh, A.V. (2011).

Kiskinis, E. & Eggan, K. (2010). Progress toward the clinical application of patient-specific

Klebe, R.J. & Mancuso, M.G. (1983). Identification of new cryoprotective agents for cultured

pluripotent stem cells. *J. Clin. Invest*, Vol. 120, No. 1, pp. (51-59)

mammalian cells. *In Vitro*, Vol. 19, No. 3 Pt 1, pp. (167-170)

DMSO-Free Programmed Cryopreservation of Fully Dissociated and Adherent Human Induced Pluripotent Stem Cells. *Stem Cells Int.*, Vol. 2011, pp. (981606- Katkov, I.I., Kim, M.S., Bajpai, R., Altman, Y.S., Mercola, M., Loring, J.F., Terskikh, A.V.,

Snyder, E.Y., & Levine, F. (2006). Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem

(1997). p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. *FEBS Lett.*, Vol. 404, No. 2-3, pp.

4-5, pp. (257-264)

No. 3, pp. (433-445)

(715-736)

(118-124)

pp. (655-656)

*Reprod.*, Vol. 25, No. 5, pp. (1271-1279)

stem cells. *Hum. Reprod.*, Vol. 18, No. 7, pp. (1404-1409)

cells. *Transfus. Med. Rev.*, Vol. 11, No. 3, pp. (224-233)

*Methods Mol. Biol.*, Vol. 368, pp. (261-270)

Review. *Transfus. Med. Hemother.*, Vol. 38, No. 2, pp. (107-123)

stem cells. *Biotechnol. Bioeng.*, Vol. 88, No. 3, pp. (299-312)

issues. *Biomaterials*, Vol. 17, No. 3, pp. (243-256)

cells. *Cryobiology*, Vol. 53, No. 2, pp. (194-205)

freeze-thaw survival rate of human embryonic stem cells. *Biosci. Rep.*, Vol. 27, No.

H.W., Lee, E.H., & Cao, T. (2006). Loss of viability during freeze-thaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. *J. Biomed. Sci.*, Vol. 13,

R., & Hovatta, O. (2010). An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cells. *Hum.* 

Blennow, E., Andang, M., & Ahrlund-Richter, L. (2003). A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic

diseases: opportunities and challenges. *Expert. Opin. Ther. Targets.*, Vol. 9, No. 4, pp.


Cryopreservation of Human Pluripotent Stem Cells: Are We Going in the Right Direction? 163

Paasch, U., Sharma, R.K., Gupta, A.K., Grunewald, S., Mascha, E.J., Thomas, A.J., Jr.,

Park, I.H., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H., Lensch, M.W.,

Rajala, K., Hakala, H., Panula, S., Aivio, S., Pihlajamaki, H., Suuronen, R., Hovatta, O., &

embryonic stem cell cultures. *Hum. Reprod.*, Vol. 22, No. 5, pp. (1231-1238) Rajala, K., Lindroos, B., Hussein, S.M., Lappalainen, R.S., Pekkanen-Mattila, M., Inzunza, J.,

pluripotent and adipose stem cells. *PLoS. One.*, Vol. 5, No. 4, pp. (e10246- Rao, M. & Condic, M.L. (2008). Alternative sources of pluripotent stem cells: scientific solutions to an ethical dilemma. *Stem Cells Dev.*, Vol. 17, No. 1, pp. (1-10) Rao, M. & Condic, M.L. (2009). Musings on genome medicine: is there hope for ethical and

Raya, A., Rodriguez-Piza, I., Guenechea, G., Vassena, R., Navarro, S., Barrero, M.J.,

Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A., & Bongso, A. (2000). Embryonic stem

Reubinoff, B.E., Pera, M.F., Vajta, G., & Trounson, A.O. (2001). Effective cryopreservation of

Revazova, E.S., Turovets, N.A., Kochetkova, O.D., Kindarova, L.B., Kuzmichev, L.N., Janus,

parthenogenetic blastocysts. *Cloning Stem Cells*, Vol. 9, No. 3, pp. (432-449) Richards, M., Fong, C.Y., Chan, W.K., Wong, P.C., & Bongso, A. (2002). Human feeders

Richards, M., Fong, C.Y., Tan, S., Chan, W.K., & Bongso, A. (2004). An efficient and safe

Richards, M., Tan, S., Fong, C.Y., Biswas, A., Chan, W.K., & Bongso, A. (2003). Comparative

human embryonic stem cells. *Stem Cells*, Vol. 21, No. 5, pp. (546-556)

embryonic stem cells. *Nat. Biotechnol.*, Vol. 20, No. 9, pp. (933-936)

induced pluripotent stem cells. *Nature*, Vol. 460, No. 7251, pp. (53-59) Raya, A., Rodriguez-Piza, I., Navarro, S., Richaud-Patin, Y., Guenechea, G., Sanchez-Danes,

Consiglio, A., Castella, M., Rio, P., Sleep, E., Gonzalez, F., Tiscornia, G., Garreta, E., Aasen, T., Veiga, A., Verma, I.M., Surralles, J., Bueren, J., & Izpisua Belmonte, J.C. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia

A., Consiglio, A., Bueren, J., & Izpisua Belmonte, J.C. (2010). A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS

cell lines from human blastocysts: somatic differentiation in vitro. *Nat. Biotechnol.*,

human embryonic stem cells by the open pulled straw vitrification method. *Hum.* 

J.D., & Pryzhkova, M.V. (2007). Patient-specific stem cell lines derived from human

support prolonged undifferentiated growth of human inner cell masses and

xeno-free cryopreservation method for the storage of human embryonic stem cells.

evaluation of various human feeders for prolonged undifferentiated growth of

safe stem cell therapeutics? *Genome Med.*, Vol. 1, No. 7, pp. (70-

cells. *Nat. Protoc.*, Vol. 5, No. 4, pp. (647-660)

*Reprod.*, Vol. 16, No. 10, pp. (2187-2194)

*Stem Cells*, Vol. 22, No. 5, pp. (779-789)

Vol. 18, No. 4, pp. (399-404)

human spermatozoa. *Biol. Reprod.*, Vol. 71, No. 6, pp. (1828-1837)

defined factors. *Nature*, Vol. 451, No. 7175, pp. (141-146)

Glander, H.J., & Agarwal, A. (2004). Cryopreservation and thawing is associated with varying extent of activation of apoptotic machinery in subsets of ejaculated

& Daley, G.Q. (2008). Reprogramming of human somatic cells to pluripotency with

Skottman, H. (2007). Testing of nine different xeno-free culture media for human

Rozell, B., Miettinen, S., Narkilahti, S., Kerkela, E., Aalto-Setala, K., Otonkoski, T., Suuronen, R., Hovatta, O., & Skottman, H. (2010). A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced


Martin, G.R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in

Martin-Ibanez, R., Stromberg, A.M., Hovatta, O., & Canals, J.M. (2009). Cryopreservation of

Martin-Ibanez, R., Unger, C., Stromberg, A., Baker, D., Canals, J.M., & Hovatta, O. (2008).

presence of a ROCK inhibitor. *Hum. Reprod.*, Vol. 23, No. 12, pp. (2744-2754) Matsumura, K., Bae, J.Y., & Hyon, S.H. (2010). Polyampholytes as cryoprotective agents for mammalian cell cryopreservation. *Cell Transplant.*, Vol. 19, No. 6, pp. (691-699) Mazur, P. (1984). Freezing of living cells: mechanisms and implications. *Am. J. Physiol*, Vol.

Mazur, P. & Cole, K.W. (1989). Roles of unfrozen fraction, salt concentration, and changes in

Mazur, P., Leibo, S.P., & Chu, E.H. (1972). A two-factor hypothesis of freezing injury.

Mazur, P. & Schneider, U. (1986). Osmotic responses of preimplantation mouse and bovine

Meryman, H.T. (2007). Cryopreservation of living cells: principles and practice. *Transfusion*,

Mollamohammadi, S., Taei, A., Pakzad, M., Totonchi, M., Seifinejad, A., Masoudi, N., &

Mountford, J.C. (2008). Human embryonic stem cells: origins, characteristics and potential

Muldrew, K. & McGann, L.E. (1994). The osmotic rupture hypothesis of intracellular

Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I.,

Nie, Y., Bergendahl, V., Hei, D.J., Jones, J.M., & Palecek, S.P. (2009). Scalable culture and

Nishigaki, T., Teramura, Y., Nasu, A., Takada, K., Toguchida, J., & Iwata, H. (2011). Highly

pluripotent stem cells. *Nature*, Vol. 448, No. 7151, pp. (313-317)

for regenerative therapy. *Transfus. Med.*, Vol. 18, No. 1, pp. (1-12)

freezing injury. *Biophys. J.*, Vol. 66, No. 2 Pt 1, pp. (532-541)

Vol. 78, No. 12, pp. (7634-7638)

247, No. 3 Pt 1, pp. (C125-C142)

Vol. 47, No. 5, pp. (935-945)

No. 3, pp. (379-391)

Vol. 25, No. 1, pp. (20-31)

cells. *Hum. Reprod.*, Vol. 24, No. 10, pp. (2468-2476)

1, pp. (1-29)

pp. (345-355)

285)

*Protoc. Stem Cell Biol.*, Vol. Chapter 1, pp. (Unit-

medium conditioned by teratocarcinoma stem cells. *Proc. Natl. Acad. Sci. U. S. A*,

dissociated human embryonic stem cells in the presence of ROCK inhibitor. *Curr.* 

Novel cryopreservation method for dissociated human embryonic stem cells in the

cell volume in the survival of frozen human erythrocytes. *Cryobiology*, Vol. 26, No.

Evidence from Chinese hamster tissue-culture cells. *Exp. Cell Res.*, Vol. 71, No. 2,

embryos and their cryobiological implications. *Cell Biophys.*, Vol. 8, No. 4, pp. (259-

Baharvand, H. (2009). A simple and efficient cryopreservation method for feederfree dissociated human induced pluripotent stem cells and human embryonic stem

Scholer, H., & Smith, A. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. *Cell*, Vol. 95,

cryopreservation of human embryonic stem cells on microcarriers. *Biotechnol. Prog.*,

efficient cryopreservation of human induced pluripotent stem cells using a dimethyl sulfoxide-free solution. *Int. J. Dev. Biol.*, Vol. 55, No. 3, pp. (305-311) Odorico, J.S., Kaufman, D.S., & Thomson, J.A. (2001). Multilineage differentiation from human embryonic stem cell lines. *Stem Cells*, Vol. 19, No. 3, pp. (193-204) Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced


Cryopreservation of Human Pluripotent Stem Cells: Are We Going in the Right Direction? 165

Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P., & Hearn, J.P. (1996).

Trump, B.F., YOUNG, D.E., ARNOLD, E.A., & Stowell, R.E. (1965). EFFECTS OF FREEZING

Unger, C., Skottman, H., Blomberg, P., Dilber, M.S., & Hovatta, O. (2008). Good

Vajta, G., Holm, P., Greve, T., & Callesen, H. (1997). Survival and development of bovine

Vajta, G., Holm, P., Kuwayama, M., Booth, P.J., Jacobsen, H., Greve, T., & Callesen, H.

Wagh, V., Meganathan, K., Jagtap, S., Gaspar, J.A., Winkler, J., Spitkovsky, D., HESCsheler,

Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi,

Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein,

Wong, R.C., Pebay, A., Nguyen, L.T., Koh, K.L., & Pera, M.F. (2004). Presence of functional

Wong, R.C., Pera, M.F., & Pebay, A. (2008). Role of gap junctions in embryonic and somatic

Wu, C.F., Tsung, H.C., Zhang, W.J., Wang, Y., Lu, J.H., Tang, Z.Y., Kuang, Y.P., Jin, W., Cui,

Xu, X., Cowley, S., Flaim, C.J., James, W., Seymour, L., & Cui, Z. (2010a). The roles of

human embryonic stem cells. *Biotechnol. Prog.*, Vol. 26, No. 3, pp. (827-837) Xu, X., Cowley, S., Flaim, C.J., James, W., Seymour, L.W., & Cui, Z. (2010b). Enhancement of

ES-cell-like state. *Nature*, Vol. 448, No. 7151, pp. (318-324)

stem cells. *Stem Cell Rev.*, Vol. 4, No. 4, pp. (283-292)

*Biotechnol. Prog.*, Vol. 26, No. 3, pp. (781-788)

bovine ova and embryos. *Mol. Reprod. Dev.*, Vol. 51, No. 1, pp. (53-58) Vajta, G. & Nagy, Z.P. (2006). Are programmable freezers still needed in the embryo

direct rehydration. *J. Reprod. Fertil.*, Vol. 111, No. 1, pp. (65-70)

blastocysts. *Biol. Reprod.*, Vol. 55, No. 2, pp. (254-259)

*Mol. Genet.*, Vol. 17, No. R1, pp. (R48-R53)

*Biotechnol.*, Vol. 25, No. 6, pp. (681-686)

796)

889)

pp. (115-122)

3, pp. (506-517)

Pluripotent cell lines derived from common marmoset (Callithrix jacchus)

AND THAWING ON THE STRUCTURE, CHEMICAL CONSTITUTION, AND FUNCTION OF CYTOPLASMIC STRUCTURES. *Fed. Proc.*, Vol. 24, pp. (S144-S168)

manufacturing practice and clinical-grade human embryonic stem cell lines. *Hum.* 

blastocysts produced in vitro after assisted hatching, vitrification and in-straw

(1998). Open Pulled Straw (OPS) vitrification: a new way to reduce cryoinjuries of

laboratory? Review on vitrification. *Reprod. Biomed. Online.*, Vol. 12, No. 6, pp. (779-

J., & Sachinidis, A. (2011). Effects of cryopreservation on the transcriptome of human embryonic stem cells after thawing and culturing. *Stem Cell Rev.*, Vol. 7, No.

J.B., Nishikawa, S., Nishikawa, S., Muguruma, K., & Sasai, Y. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. *Nat.* 

B.E., & Jaenisch, R. (2007). In vitro reprogramming of fibroblasts into a pluripotent

gap junctions in human embryonic stem cells. *Stem Cells*, Vol. 22, No. 6, pp. (883-

L., Liu, W., & Cao, Y.L. (2005). Improved cryopreservation of human embryonic stem cells with trehalose. *Reprod. Biomed. Online.*, Vol. 11, No. 6, pp. (733-739) Xiao, M. & Dooley, D.C. (2003). Assessment of cell viability and apoptosis in human

umbilical cord blood following storage. *J. Hematother. Stem Cell Res.*, Vol. 12, No. 1,

apoptotic pathways in the low recovery rate after cryopreservation of dissociated

cell recovery for dissociated human embryonic stem cells after cryopreservation.


Ronaghi, M., Erceg, S., Moreno-Manzano, V., & Stojkovic, M. (2010). Challenges of stem cell

Schneider, U. & Maurer, R.R. (1983). Factors affecting survival of frozen-thawed mouse

Stojkovic, M., Lako, M., Stojkovic, P., Stewart, R., Przyborski, S., Armstrong, L., Evans, J.,

Strelchenko, N., Verlinsky, O., Kukharenko, V., & Verlinsky, Y. (2004). Morula-derived human embryonic stem cells. *Reprod. Biomed. Online.*, Vol. 9, No. 6, pp. (623-629) Sum, A.K. & de Pablo, J.J. (2003). Molecular simulation study on the influence of

Sum, A.K., Faller, R., & de Pablo, J.J. (2003). Molecular simulation study of phospholipid

Sun, N., Longaker, M.T., & Wu, J.C. (2010). Human iPS cell-based therapy: considerations

T'joen, V., De, G.L., Declercq, H., & Cornelissen, M. (2011). An Efficient, Economical Slow-

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S.

Takahashi, K. & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse

Thirumala, S., Gimble, J.M., & Devireddy, R.V. (2010). Evaluation of methylcellulose and

Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S.,

Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P., Becker, R.A., & Hearn,

before clinical applications. *Cell Cycle*, Vol. 9, No. 5, pp. (880-885)

Silva, J. & Smith, A. (2008). Capturing pluripotency. *Cell*, Vol. 132, No. 4, pp. (532-536) Skottman, H., Stromberg, A.M., Matilainen, E., Inzunza, J., Hovatta, O., & Lahesmaa, R.

in an undifferentiated stage. *Stem Cells*, Vol. 24, No. 1, pp. (151-167)

stem cells. *Reprod. Biomed. Online.*, Vol. 4, No. 1, pp. (56-61)

embryos. *Biol. Reprod.*, Vol. 29, No. 1, pp. (121-128)

vitro culture. *Stem Cells*, Vol. 22, No. 5, pp. (790-797)

factors. *Cell*, Vol. 131, No. 5, pp. (861-872)

*Science*, Vol. 282, No. 5391, pp. (1145-1147)

*A*, Vol. 92, No. 17, pp. (7844-7848)

6, pp. (3636-3645)

5, pp. (2830-2844)

*Dev.*,

(663-676)

pp. (513-522)

therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? *Stem Cells*, Vol. 28, No. 1, pp. (93-99) Sathananthan, H., Pera, M., & Trounson, A. (2002). The fine structure of human embryonic

(2006). Unique gene expression signature by human embryonic stem cells cultured under serum-free conditions correlates with their enhanced and prolonged growth

Herbert, M., Hyslop, L., Ahmad, S., Murdoch, A., & Strachan, T. (2004). Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in

dimethylsulfoxide on the structure of phospholipid bilayers. *Biophys. J.*, Vol. 85, No.

bilayers and insights of the interactions with disaccharides. *Biophys. J.*, Vol. 85, No.

Freezing Method for Large-Scale Human Embryonic Stem Cell Banking. *Stem Cells* 

(2007). Induction of pluripotent stem cells from adult human fibroblasts by defined

embryonic and adult fibroblast cultures by defined factors. *Cell*, Vol. 126, No. 4, pp.

dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells. *Stem Cells Dev.*, Vol. 19, No. 4,

& Jones, J.M. (1998). Embryonic stem cell lines derived from human blastocysts.

J.P. (1995). Isolation of a primate embryonic stem cell line. *Proc. Natl. Acad. Sci. U. S.* 


**Part 3** 

**Human Assisted** 

**Reproduction Techniques (ART)** 

